Risk based development and manufacturing of biosimilars
The development of biosimilars presents a unique risk profile to biopharmaceutical companies
Articles, journals and conferences in one search. An exact title, DOI or ISSN is listed first.
In the search box: "exact phrase" · -leave out · OR · prefix* · title: author: journal:
The development of biosimilars presents a unique risk profile to biopharmaceutical companies
The Bacillus (B.) cereus group (also called B. cereus sensu lato or
Introduction: A significant proportion of traumatic injuries sustained during the recent conflicts
To determine the organic constituents of ambient ultrafine particles (<0.18 um) and
Context: Even in today’s information age, finding comprehensive and valid information
Avaxia Biologics is a clinical-stage biopharmaceutical company developing gut-targeted bio
Avaxia Biologics is a clinical-stage biopharmaceutical company developing gut-targeted biobetter
Sialic acid supports nerve cell regeneration, differentiation and neuronal plasticity. Especially, polysialic
microbe isolated from the common cord moss, Methylobacterium funariae, as described by Schauer and Kutschera (2011). Based on samples of M. Funariae which was provided to the colleagues
Introduction: Prevalence of hookah or waterpipe smoking is increasing in the United
For authors and organisers
Find the right journal for your paper and submit your manuscript.